PH12012500410A1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- PH12012500410A1 PH12012500410A1 PH12012500410A PH12012500410A PH12012500410A1 PH 12012500410 A1 PH12012500410 A1 PH 12012500410A1 PH 12012500410 A PH12012500410 A PH 12012500410A PH 12012500410 A PH12012500410 A PH 12012500410A PH 12012500410 A1 PH12012500410 A1 PH 12012500410A1
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical composition
- carbonyl
- tetrahydrothiazolo
- ethanediamide
- chloropyridin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 2
- -1 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c] pyridin-2-yl Chemical group 0.000 abstract 1
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
To provide pharmaceutical preparation exhibiting satisfactory dissolution property in a wide pH range. The pharmaceutical composition is characterized by containing (A) N[1]-(5-chloropyridin-2-yl)-N[2]-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c] pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide, represented by the formula (1), a pharmacologically acceptable salt thereof, or a hydrate of any of these, and (B) one or more species selected from the group consisting of a sugar alcohol and a water-swelling additive.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007087327 | 2007-03-29 | ||
| JP2008129846 | 2008-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12012500410A1 true PH12012500410A1 (en) | 2015-10-05 |
Family
ID=55305300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12012500410A PH12012500410A1 (en) | 2007-03-29 | 2012-02-28 | Pharmaceutical composition |
Country Status (1)
| Country | Link |
|---|---|
| PH (1) | PH12012500410A1 (en) |
-
2012
- 2012-02-28 PH PH12012500410A patent/PH12012500410A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY149356A (en) | Pharmaceutical composition | |
| WO2006010423A3 (en) | Azaindole inhibitors of mtp and apob | |
| MX2010006799A (en) | Benzofuropyrimidinones as protein kinase inhibitors. | |
| BR0316350A (en) | Diaminotriazoles useful as protein kinase inhibitors | |
| NZ594930A (en) | Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1 | |
| UY30183A1 (en) | QUINOLINE DERIVATIVES | |
| TNSN08260A1 (en) | [ (1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders | |
| BRPI0413151A (en) | amino propanol derivatives | |
| TW200634012A (en) | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | |
| MX2009003985A (en) | Phenylacetamides useful as protein kinase inhibitors. | |
| PT2432766E (en) | Anticancer compound and pharmaceutical composition containing the same | |
| WO2007102127A3 (en) | New amines | |
| MY147262A (en) | 1-aza-bicyclo[3.3.1]nonanes | |
| MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
| BRPI0511610A (en) | amino propanol derivatives | |
| WO2007096072A3 (en) | New pyridin-3-amine derivatives | |
| ATE457027T1 (en) | SUBSTITUTED 1,4,8-TRIAZASPIROÄ4.5 DECAN-2-ON COMPOUNDS FOR THE TREATMENT OF OBESITY | |
| NO20084177L (en) | Substituted Imidazo [2,1-B] Thiazole Compounds and Their Use for Drug Production | |
| WO2007099509A3 (en) | Primary amines as renin inhibitors | |
| DK1869038T3 (en) | Substituted 5,6,7,8-tetrahydro-imidazole [1,2-a] pyridin-2-ylamine compounds and their use in the manufacture of drugs | |
| PH12021550557A1 (en) | Furo[3,4-b]pyrrole-containing btk inhibitor | |
| BRPI0510032A (en) | thiophene heteroaryl amines | |
| ATE518858T1 (en) | PYRROLOÄ3,2-CÜPYRIDINE DERIVATIVES AND PRODUCTION PROCESS THEREOF | |
| MY146404A (en) | Novel piperidine carboxylic acid amide derivatives | |
| PH12012500410A1 (en) | Pharmaceutical composition |